MyCOPDTeam

Tezspire (tezepelumab) isn't something that currently appears in available COPD treatment information, so it's hard to speak to experiences with it specifically for COPD management.

You may be thinking of Nucala (mepolizumab), which is a similar biologic injection that was recently FDA-approved for COPD. It targets a Show Full Answer

Tezspire (tezepelumab) isn't something that currently appears in available COPD treatment information, so it's hard to speak to experiences with it specifically for COPD management.

You may be thinking of Nucala (mepolizumab), which is a similar biologic injection that was recently FDA-approved for COPD. It targets a specific type of inflammation in people with high eosinophil counts.

Here's what's known about Nucala for COPD:

- It's given as a once-monthly injection
- In clinical trials, it reduced moderate and severe flare-ups by about 21% compared to placebo
- It may mean fewer hospital visits for those who qualify
- It's typically considered for people who still have frequent flare-ups despite using triple inhaler therapy

The best step would be to speak with your doctor about whether a biologic like Nucala might be appropriate for your situation, including whether eosinophil testing makes sense for you.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

First Biologic for Eosinophilic COPD Cuts Flare-Ups by 21%